PROTAC Ligase System Design Services

Name: E3 Ligase System Services
Brand: BOC Sciences

In targeted protein degradation (TPD), the E3 ligase system is not simply a supporting component—it is a decisive driver of degrader potency, selectivity, cellular activity, tissue relevance, and overall project feasibility. The selection of an appropriate E3 ligase, the design of suitable ligase-binding elements, and the establishment of reliable ubiquitination systems can determine whether a PROTAC, molecular glue, or emerging degradation strategy produces meaningful target degradation in the intended biological context. BOC Sciences provides integrated E3 Ligase System Services to help pharmaceutical, biotechnology, and drug discovery teams build customized ligase recruitment strategies, optimize E3 ligase ligands, engineer functional ligase systems, and validate ubiquitination-driven degradation mechanisms. From E3 ligase ligand design to assay development and degrader optimization, our services are designed to reduce uncertainty in early TPD programs and support rational decision-making throughout discovery research.

Request a Consultation Explore Services

Services

BOC Sciences E3 Ligase System Service Capabilities

E3 Ligase Selection and Feasibility Assessment We help clients select suitable E3 ligases based on target biology, cellular localization, expression profile, ligandability, available structural information, and degrader format. Our team evaluates commonly used systems such as CRBN, VHL, IAP, and MDM2, as well as alternative E3 ligases with project-specific advantages for cell type selectivity, resistance exploration, or differentiated degradation profiles.
Small-Molecule E3 Ligase Ligand Development BOC Sciences supports the discovery, redesign, and optimization of small-molecule E3 ligase ligands. We focus on binding affinity, synthetic accessibility, linker exit vector compatibility, physicochemical properties, and retained ligase recruitment activity, enabling clients to build degrader candidates with a stronger mechanistic foundation.
Peptide and Motif-Based Ligase Recruitment Design For E3 systems where peptide recognition or substrate-mimicking motifs are relevant, we provide peptide design for E3 ubiquitin ligase recruitment. Our approach considers sequence optimization, binding interface mapping, stability enhancement, and conjugation compatibility for research programs involving peptide-based degraders or novel ubiquitination strategies.
Ligase Engineering and Recombinant Production We provide ligase engineering and production support for assay-ready E3 ligase proteins, ligase complexes, mutants, domains, and functional constructs. These materials can be tailored for biochemical assays, interaction studies, ubiquitination experiments, and structure-guided degrader optimization.
Ubiquitination System Construction BOC Sciences designs and assembles E1/E2/E3/substrate ubiquitination systems to evaluate whether a selected ligase can productively ubiquitinate the protein of interest. Through protein ubiquitination services, we help clients characterize ubiquitin transfer efficiency, chain formation, substrate dependency, and degrader-induced ubiquitination activity.
Functional Validation of E3 Ligase Recruitment We validate E3 ligase recruitment using binding assays, ternary complex analysis, ubiquitination assays, degradation assays, and cellular readouts. These data help clients compare ligase systems, identify productive POI-ligase pairings, and prioritize degrader designs with stronger translational research potential.

Need to Identify the Right E3 Ligase for Your Degrader Program?

BOC Sciences helps you evaluate ligase biology, ligand compatibility, ternary complex formation, and ubiquitination feasibility for rational TPD design.

Get a Quote

Platforms

Technical Platforms Supporting E3 Ligase System Development

Bioinformatics and Ligase Profiling Platform Our team integrates public datasets, structural databases, pathway knowledge, and target-specific biology to prioritize E3 ligases with the highest probability of success for a given degrader project. E3 ligase expression and localization analysis Target-ligase proximity and pathway relevance evaluation Ligase family comparison and candidate ranking
Structure-Based Ligase-Ligand Design Platform We use structure-guided strategies to optimize ligase-binding motifs, improve exit vector selection, and design ligand-linker architectures compatible with productive ternary complex formation. Molecular docking for protein-ligand binding evaluation Ligase-ligand interaction modeling Exit vector and linker attachment site analysis
Virtual Screening and Ligand Discovery Platform For ligases with limited chemical matter, BOC Sciences applies screening strategies to identify potential ligase binders, fragment-like starting points, or motif-inspired scaffolds for further optimization. Virtual screening of ligand candidates Fragment and scaffold prioritization Hit-to-lead optimization support
Biochemical Binding and Activity Platform We assess ligand-ligase binding, ligase activity, and degrader-induced recruitment using quantitative biochemical methods to support confident system selection. Binding affinity measurement E3 ubiquitin ligase activity assay SPR, BLI, fluorescence polarization, and thermal shift assays
Ternary Complex and Ubiquitination Analysis Platform Because ligase binding alone does not guarantee target degradation, we evaluate whether the POI, degrader, and E3 ligase form productive complexes capable of driving ubiquitination. PROTAC ternary complex assay In vitro ubiquitination assay development Ubiquitin chain and substrate modification analysis
PROTAC and Degrader Optimization Platform BOC Sciences connects E3 ligase system design with degrader construction, enabling coordinated optimization of the POI ligand, ligase ligand, linker, and cellular degradation performance. PROTAC design services Linker architecture and physicochemical tuning Cellular degradation and selectivity profiling

Significance

Why E3 Ligase System Design Matters in TPD?

Determines Degradation Efficiency

E3 ligase choice directly influences ubiquitination efficiency, ternary complex stability, degradation kinetics, and maximum degradation level. A well-matched ligase system can convert a weak degrader concept into a biologically active molecule.

Improves Cellular Context Relevance

Different ligases show distinct expression patterns and subcellular distributions. Matching ligase biology with target localization and disease-relevant cell models can increase the probability of meaningful degradation.

Expands Beyond Conventional Systems

While CRBN and VHL remain widely used, alternative E3 ligases can offer new opportunities for selectivity, resistance exploration, and differentiated degrader profiles in challenging targets.

Reduces Late-Stage Design Failure

Early assessment of ligandability, binding geometry, ubiquitination competence, and cellular activity helps clients avoid investing resources in degrader systems with poor mechanistic feasibility.

Workflow

Our E3 Ligase System Service Workflow

01

Project Requirement Analysis

We clarify the target protein, disease-relevant cell context, degrader modality, available ligands, desired selectivity profile, and key decision points for E3 ligase system development.

02

E3 Ligase Candidate Mapping

Candidate ligases are mapped based on expression, localization, ligandability, structural information, reported ligands, protein interaction context, and compatibility with the intended degrader strategy.

03

Ligase Ligand or Motif Design

We design or optimize small-molecule ligands, peptide motifs, or ligand-linker handles to support effective E3 recruitment and degrader assembly.

04

Modeling and Ternary Complex Prediction

Molecular docking, structural modeling, and spatial orientation analysis are applied to estimate whether the POI, degrader, and E3 ligase can form a productive complex.

05

Ligase Protein Preparation

Recombinant E3 ligase constructs, domains, complexes, or engineered variants are prepared when needed for binding, activity, ubiquitination, and interaction assays.

06

Biochemical Validation

Binding affinity, ligase activity, ternary complex formation, and substrate ubiquitination are evaluated using fit-for-purpose biochemical assays.

07

Cellular Degradation Evaluation

Selected degrader-ligase systems are assessed in relevant cellular models to measure target degradation, selectivity, dose response, and degradation kinetics.

08

Optimization and Technical Reporting

We provide data interpretation, structure-activity relationship insights, recommended ligase strategies, and next-step optimization plans for continued degrader development.

Build a More Rational E3 Ligase Recruitment Strategy

Partner with BOC Sciences to evaluate, design, and validate customized E3 ligase systems for your targeted protein degradation program.

Talk to Experts

Why Choose Us

BOC Sciences Advantages in E3 Ligase System Services

Integrated TPD Expertise

Our team combines medicinal chemistry, protein science, structural biology, and degradation biology to support E3 ligase system design from multiple technical angles.

Broad Ligase Coverage

We support established E3 ligases and emerging ligase systems, helping clients move beyond default choices when the target biology requires alternative strategies.

Custom Ligand Optimization

Ligase ligands can be optimized for binding, solubility, linker compatibility, synthetic route feasibility, and degrader construction requirements.

Mechanism-Focused Validation

We do not rely on binding data alone. Our services connect ligand-ligase interaction, ternary complex formation, ubiquitination, and downstream degradation readouts.

Flexible Service Modules

Clients can access individual modules such as ligand design, ligase production, ubiquitination assays, or complete end-to-end E3 ligase system development.

Actionable Data Interpretation

We provide clear technical reports that help project teams compare ligase options, understand failure points, and plan rational next-step optimization.

Applications

Applications of E3 Ligase System Services

PROTAC Discovery and Optimization

E3 ligase system services support the rational design of bifunctional degraders by identifying ligase partners, optimizing ligase-binding moieties, and validating degradation mechanisms.

Molecular Glue Research

For molecular glue projects, E3 ligase profiling and substrate recruitment analysis help reveal whether a small molecule promotes productive neosubstrate engagement and ubiquitination.

Alternative E3 Ligase Exploration

Alternative ligase strategies are valuable when CRBN or VHL systems show weak activity, poor cellular relevance, resistance concerns, or inadequate selectivity in the desired model.

Target-Specific Degrader Strategy

Different targets require different ligase systems. Our platform supports target classes such as kinases, transcription factors, epigenetic proteins, scaffold proteins, and signaling regulators.

Mechanistic Ubiquitination Studies

E3 ligase systems can be built to study substrate ubiquitination, chain type preference, ligase dependency, and degrader-induced changes in protein turnover.

Resistance and Selectivity Investigation

Comparing different E3 ligases helps researchers understand why certain degraders fail, whether alternative ligases restore activity, and how selectivity can be improved.

Case Study

Client Success Stories: E3 Ligase System Services

Project Background

A biotechnology client was developing a bifunctional degrader targeting a mutant KRAS signaling model. The original degrader used a conventional ligase-recruiting handle and showed detectable target binding but weak cellular degradation. The client needed to determine whether the failure was caused by the POI ligand, linker geometry, or an unsuitable E3 ligase system.

Technical Challenges

The target protein had limited accessible surface area for productive ubiquitination, and the initial ligase system showed poor spatial compatibility in ternary complex modeling. Cellular data also suggested that the selected ligase was not optimal in the client's disease-relevant cell model.

BOC Sciences Solutions

Ligase Candidate Ranking: We evaluated multiple ligases based on expression, localization, reported ligand availability, structural information, and predicted proximity to the KRAS degrader binding orientation.
Ligand-Linker Redesign: Twelve ligand-linker designs were generated using different linker exit vectors and flexibility profiles to improve POI-ligase alignment.
Mechanistic Validation: Binding affinity, ternary complex formation, and ubiquitination assays were performed to compare the original and alternative ligase systems under matched assay conditions.

Project Outcomes

BOC Sciences identified two alternative E3 ligase systems with stronger ternary complex formation than the original design. Among 12 redesigned candidates, one analog showed the best balance of ligase recruitment, linker geometry, and target ubiquitination, producing a clear increase in KRAS degradation in the client's cellular model. The client received a prioritized ligase strategy and a rational optimization path for next-round degrader design.

Project Background

A pharmaceutical research team had developed a BTK-targeting PROTAC based on a CRBN-recruiting ligand. Although the molecule displayed strong BTK binding and acceptable biochemical activity, cellular degradation plateaued at a moderate level. The client asked BOC Sciences to explore whether switching the E3 ligase system could improve degradation depth and selectivity.

Technical Challenges

The initial degrader generated partial degradation and inconsistent activity across cell lines. Structural analysis suggested that CRBN recruitment placed the target lysine region in a less favorable orientation, while linker hydrophobicity also contributed to cellular variability.

BOC Sciences Solutions

Comparative Ligase Strategy: We compared CRBN-, VHL-, and IAP-recruiting formats using matched BTK-binding warheads and varied linker lengths.
Linker Optimization: A focused set of PEG, alkyl, and semi-rigid linkers was designed to identify geometries that favored productive BTK-E3 complex formation.
Assay Integration: Ternary complex assays, cellular degradation assays, and ubiquitination analysis were integrated to distinguish true ligase-driven improvement from nonspecific potency changes.

Project Outcomes

BOC Sciences synthesized and evaluated 24 degrader analogs across three ligase recruitment systems. The optimized VHL-recruiting candidate showed stronger ternary complex stability and deeper BTK degradation than the original CRBN-based molecule, while one semi-rigid linker design provided the most consistent performance across tested cellular models. The client used these findings to focus subsequent medicinal chemistry around the VHL-based system.

Frequently Asked Questions (FAQ)

Frequently Asked Questions

Still have questions?

Contact Us

How do you choose the right E3 ligase?

Selecting an E3 ligase is not simply a matter of choosing the most widely used option. It requires a combined assessment of target protein localization, cellular context, E3 expression profile, ligand accessibility, the likelihood of productive ternary complex formation, and downstream ubiquitination efficiency. In targeted protein degradation, CRBN and VHL are still the most common starting points, but many projects now explore emerging systems such as DCAF, KEAP1, and FBXO to address tissue selectivity, resistance risks, and limited target coverage. For clients, the key is to establish a rational match between the target protein, the E3 ligase, and the chemical recruiter, rather than relying on a standard platform by default.

What experiments are needed for E3 ligase screening?

A meaningful E3 ligase screening program should not stop at a single binding assay. It usually requires a staged workflow covering both biochemical and cellular validation. Key steps often include E3 protein preparation and activity confirmation, ligand binding analysis, ubiquitination-related biochemical assays, ternary complex evaluation, cellular degradation readouts, and, when needed, proteomics-based selectivity assessment. For drug development teams, this layered strategy is important because it helps distinguish compounds that merely bind from those that can truly drive productive target degradation. At BOC Sciences, we place particular emphasis on linking screening, mechanism validation, and follow-up optimization into one integrated service path.

Why is ternary complex validation so important?

In an E3 ligase system, the outcome is often determined not only by individual binding to the target protein or the E3 ligase, but by whether the degrader can induce a stable and productive ternary complex under biologically relevant conditions. The stability, cooperativity, and structural compatibility of that ternary complex strongly influence ubiquitination probability and the final degradation response. For this reason, clients evaluating an E3 ligase system should look beyond simple affinity measurements and ask whether the system can form a functional ternary complex that consistently drives downstream degradation. This is one of the most critical factors in deciding whether a degradation concept can advance into a practical development program.

How can degradation performance be evaluated reliably?

Reliable degradation evaluation should be based on multiple orthogonal indicators rather than a single protein reduction result. A robust assessment normally includes DC50, Dmax, time dependence, dose dependence, cellular activity window, protein recovery behavior, and mechanism-based rescue experiments where appropriate. These data help confirm that the observed protein loss is truly driven by an E3 ligase-mediated ubiquitin-proteasome pathway rather than transcriptional suppression, translational effects, or nonspecific cytotoxicity. For drug development clients, this level of validation is especially important because targeted degraders act catalytically, and weak off-target effects can become amplified over longer treatment periods. BOC Sciences supports these studies through coordinated assay design and mechanism-focused evaluation strategies.

Are there options beyond CRBN and VHL?

Yes, and this is becoming one of the most important directions in E3 ligase system development. Although CRBN and VHL remain the most established ligases because of their mature toolsets and well-characterized ligands, the field is actively expanding toward additional recruitable E3 ligases. These newer options may improve target tractability, support tissue-specific strategies, and reduce limitations seen in conventional systems. For clients building differentiated degradation programs, it is often valuable to assess alternative E3 ligases early rather than only after a standard approach fails. The value of E3 Ligase System Services lies in this broader capability to evaluate both classical and emerging ligase systems in a systematic and development-oriented manner.

Testimonials

Client Testimonials on E3 Ligase System Services

Clear Ligase Selection Strategy

"Our team had several degrader concepts but no clear rationale for choosing the E3 ligase system. BOC Sciences provided a structured comparison of ligase expression, ligandability, and assay feasibility, which helped us make confident design decisions."

— Dr. Mercer, Discovery Chemistry Director

Mechanistic Insight Beyond Binding Data

"The most valuable part of the project was the integration of binding, ternary complex, and ubiquitination data. BOC Sciences helped us understand why one ligase system worked while another failed, rather than simply reporting assay numbers."

— Principal Scientist, European Biotech Company

Efficient Alternative Ligase Exploration

"We initially focused only on CRBN and VHL, but our target required a more customized approach. BOC Sciences designed a focused alternative ligase evaluation plan and identified a more promising recruitment strategy for our program."

— Dr. Fischer, Head of Targeted Degradation Research

Strong Protein and Assay Support

"The recombinant ligase preparation and ubiquitination assay setup were highly useful for our internal decision-making. The BOC Sciences team delivered practical recommendations that directly shaped our next design cycle."

— Senior Project Manager, US Pharmaceutical R&D Team